Amanote Research
Register
Sign In
Table 3: Circulating Immune Cells as a Percentage of the Total PBMC in Stage II/III LCC and RCC.
doi 10.7717/peerj.4153/table-3
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Table 1: Clinicopathological Characteristics of LCC and RCC Patients.
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Total Tax Revenue: As a Percentage of GDP
The Relation of Circulating Antipneumococcal Immune Substances to the Course of Lobar Pneumonia Iii. Injected Immune Substances (Antipneumococcus Serum, Types I and Ii)
Journal of Clinical Investigation
Medicine
Supplemental Information 3: Table S1. The Percentage of Clean Reads.
Mobilization of Endothelial Progenitor Cells in Patients With Hypertensive Disease Stage Ii-Iii
Siberian Medical Review
Total Public Expenditure as a Percentage of GDP (2000, 2005)
Education at a Glance
Table 1: Multivariate Cox PHR Based on 3 Immune Cells.
Table 3: Results of Spray Experiments in Both Log Scale and Percentage.
